Zymeworks and ALX Oncology Announce Clinical Collaboration Evaluating Zanidatamab with the CD47 Blocker ALX148 in Patients with Advanced HER2‑Expressing Breast Cancer

Zymeworks and ALX Oncology Announce Clinical Collaboration Evaluating Zanidatamab with the CD47 Blocker ALX148 in Patients with Advanced HER2‑Expressing Breast Cancer

VANCOUVER, British Columbia & BURLINGAME, Calif.–(BUSINESS WIRE)–
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics,and ALX Oncology Holdings Inc. (NASDAQ: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced they have entered into a clinical collaboration to evaluate the combination of Zymeworks’ zanidatamab (formerly ZW25), a HER2-targeted bispecific antibody, and ALX148, a next-generation CD47 blocker, for the treatment of patients with advanced HER2-expressing breast cancer and other solid tumors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201116005959/en/

Under the terms of the agreement, Zymeworks will conduct an open label, multi-center Phase 1b study to assess the safety and efficacy of the combination of zanidatamab and ALX148 in a two-part study. The first part of the trial will evaluate the safety of the combination treatment. The second part of the trial will evaluate the safety, tolerability and anti-tumor activity of the combination in separate cohorts of subjects with HER2-positive breast cancer, HER2-low breast cancer, and non-breast HER2-expressing solid tumors.

“In addition to broad anti-tumor activity, zanidatamab’s safety profile supports combination approaches with other therapeutics,” said Diana Hausman, M.D., Chief Medical Officer at Zymeworks. “Our collaboration with ALX Oncology and their CD47 blocker, ALX148, has the potential to further expand the opportunity for zanidatamab to provide benefit to a broader population of patients, including those with advanced HER2‑expressing breast cancer.”

Zanidatamab is designed to have multiple mechanisms of action, including immune clearance of HER2-expressing tumor cells by macrophages through antibody-dependent cellular phagocytosis (ADCP). CD47 is a “don’t eat me” signal that acts as a checkpoint inhibitor to macrophages. Cancer cells that express CD47 are resistant to immune clearance even when targeted with therapeutic antibodies. Treatment with zanidatamab plus ALX148 has the potential to increase the immune clearance of HER2-expressing cancer cells by combining a biparatopic antibody capable of binding at higher density than monospecific antibodies with a molecule that blocks CD47 on the same targeted cancer cells.

“We are excited about this collaboration with Zymeworks that combines two promising next-generation anti-cancer agents, a HER2-targeted bispecific antibody with a CD47 blocker, to enhance their potential activity in treating patients with advanced breast cancer,” said Jaume Pons, Ph.D., Founder, President and Chief Executive Officer of ALX Oncology. “ALX148 was designed for safe use in combination to maximize clinical activity with a range of anti-cancer agents. This collaboration builds on the promising anti-tumor activity observed in clinical trials of ALX148 combined with a HER2-targeted therapy in patients with advanced HER2-positive gastric and gastroesophageal cancer.”

Zanidatamab is in advanced clinical development, actively enrolling a pivotal study in patients with previously-treated HER2 gene-amplified biliary tract cancer. In addition, five active Phase 2 programs are underway, and Zymeworks plans to initiate a second pivotal study for zanidatamab as first-line treatment for advanced HER2‑positive gastroesophageal adenocarcinomas.

Phase 1 studies of ALX148 have been conducted in combination with tumor antigen targeted antibodies, a checkpoint inhibitor and chemotherapy. Preliminary results from ASPEN-01, the ALX148 Phase 1b study, were presented at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting [abstract 404]. ALX148 displayed promising initial clinical activity in patients with solid tumors, including advanced HER2-positive gastric and gastroesophageal cancer where ALX148 was well tolerated in combination with an anti-HER2 specific antibody and chemotherapy with no maximum tolerated dose reached. ALX Oncology plans to continue the advancement of ALX148 as a potential treatment for a range of solid tumor indications and is currently also in development in patients with higher risk myelodysplastic syndromes (ASPEN-02).

About Zymeworks Inc.

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab (ZW25), is a novel Azymetric™ bispecific antibody currently in a registration-enabling clinical trial for refractory HER2+ biliary tract cancer as well as several Phase 2 clinical trials for HER2+ gastroesophageal and breast cancers. Zymeworks’ second clinical candidate, ZW49, is a bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks’ proprietary ZymeLink™ linker-cytotoxin. Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For more information, visit www.zymeworks.com.

About ALX Oncology

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology’s lead product candidate, ALX148, is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. ALX148 has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents. ALX Oncology intends to continue clinical development of ALX148 for the treatment of a range of solid tumor indications and myelodysplastic syndromes. For more information, please visit ALX Oncology’s website at www.alxoncology.com.

Zymeworks Cautionary Note Regarding Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of Canadian securities laws, or collectively, forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements that relate to Zymeworks’ expectations regarding the beneficial characteristics, safety, and therapeutic effects of zanidatamab, its planned trials combining zanidatamab and ALX148, the potential benefits of that combination, and other information that is not historical information. When used herein, words such as “will”, “may”, “plan”, “potential”, and similar expressions are intended to identify forward-looking statements. In addition, any statements or information that refer to expectations, beliefs, plans, projections, objectives, performance or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking. All forward-looking statements are based upon Zymeworks’ current expectations and various assumptions. Zymeworks believes there is a reasonable basis for its expectations and beliefs, but they are inherently uncertain. Zymeworks may not realize its expectations, and its beliefs may not prove correct. Actual results could differ materially from those described or implied by such forward-looking statements as a result of various factors, including, without limitation, market conditions and the factors described under “Risk Factors” in Zymeworks’ Quarterly Report on Form 10-Q for its quarter ended September 30, 2020 (a copy of which may be obtained at www.sec.gov and www.sedar.com). Consequently, forward-looking statements should be regarded solely as Zymeworks’ current plans, estimates and beliefs. Investors should not place undue reliance on forward-looking statements. Zymeworks cannot guarantee future results, events, levels of activity, performance or achievements. Zymeworks does not undertake and specifically declines any obligation to update, republish, or revise any forward-looking statements to reflect new information, future events, or circumstances or to reflect the occurrences of unanticipated events, except as may be required by law.

ALX Oncology Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on ALX Oncology’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause its actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding ALX Oncology’s clinical pipeline and expectations regarding the beneficial characteristics, safety, efficacy and therapeutic effects of ALX148. These and other risks are described more fully in ALX Oncology’s filings with the Securities and Exchange Commission (“SEC”), including ALX Oncology’s Quarterly Report on Form 10-Q, filed with the SEC on November 12, 2020, and other documents that ALX Oncology subsequently files with the SEC from time to time. Except to the extent required by law, ALX Oncology undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Zymeworks Inc.

Investor Inquiries

Ryan Dercho, Ph.D.

(604) 678-1388

[email protected]

Tiffany Tolmie

(604) 678-1388

[email protected]

Media Inquiries

Mary Klem

(604) 678-1388

[email protected]

ALX Oncology

Investor Inquiries

Peter Garcia

Chief Financial Officer, ALX Oncology

(650) 466-7125 Ext. 113

[email protected]

Argot Partners

(212)-600-1902

[email protected]

Media Inquiries

Karen Sharma

MacDougall

(781) 235-3060

[email protected]

KEYWORDS: California United States North America Canada

INDUSTRY KEYWORDS: Biotechnology Health Pharmaceutical Clinical Trials Oncology

MEDIA:

Logo
Logo
Logo
Logo

Camden Property Trust Announces Participation in Nareit’s REITworld 2020 Annual Conference

Camden Property Trust Announces Participation in Nareit’s REITworld 2020 Annual Conference

HOUSTON–(BUSINESS WIRE)–
Camden Property Trust (NYSE: CPT) (the “Company”) announced today that it will participate in Nareit’s REITworld 2020 Annual Conference which is being held virtually November 17-19, 2020. Camden’s roundtable discussion has been scheduled for Wednesday, November 18, 2020 at 1:45 PM Eastern Time. The event will be webcast live in a listen-only mode and can be accessed by registering for the event at https://reit.cventevents.com/event/2e1cd484-8bec-4877-ad65-73cd599730f8/regProcessStep1. An audio archive of the event will be available on the Company’s website at camdenliving.com in the Investors section on or after Friday, November 20, 2020. A copy of Camden’s most recent investor presentation will also be available in the Investors section of the Company’s website.

Camden Property Trust, an S&P 400 Company, is a real estate company primarily engaged in the ownership, management, development, redevelopment, acquisition, and construction of multifamily apartment communities. Camden owns interests in and operates 165 properties containing 56,383 apartment homes across the United States. Upon completion of 9 properties currently under development, the Company’s portfolio will increase to 59,104 apartment homes in 174 properties. Camden has been recognized as one of the 100 Best Companies to Work For® by FORTUNE magazine for 13 consecutive years, most recently ranking #18. The Company also received a Glassdoor Employees’ Choice Award in 2020, ranking #25 for large U.S. companies.

For additional information, please contact Camden’s Investor Relations Department at (713) 354-2787 or access our website at camdenliving.com.

Kim Callahan, 713-354-2549

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Residential Building & Real Estate Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo

Slack Announces Date of Third Quarter Fiscal Year 2021 Financial Results

Slack Announces Date of Third Quarter Fiscal Year 2021 Financial Results

SAN FRANCISCO–(BUSINESS WIRE)–
Slack Technologies, Inc. (NYSE:WORK) today announced that it will report its financial results for the third quarter of fiscal year 2021, ended October 31, 2020, following the close of the U.S. markets on Wednesday, December 9, 2020. Slack will host a conference call that day at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss the results.

To access the conference call, participants need to register in advance online at http://www.directeventreg.com/registration/event/5993745. A live webcast of the conference call will be available on the Slack Investor Relations website, investor.slackhq.com. Following the completion of the call, a replay will also be made available at investor.slackhq.com.

About Slack

Slack has transformed business communication. It’s the leading channel-based messaging platform, used by millions to align their teams, unify their systems, and drive their businesses forward. Only Slack offers a secure, enterprise-grade environment that can scale with the largest companies in the world. It is a new layer of the business technology stack where people can work together more effectively, connect all their other software tools and services, and find the information they need to do their best work. Slack is where work happens.

Slack and the Slack logo are trademarks of Slack Technologies, Inc. or its subsidiaries in the U.S. and/or other countries. Other names and brands may be claimed as the property of others.

Jesse Hulsing

Investor Relations

[email protected]

Steve Sharpe

Media Relations

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Data Management Technology Mobile/Wireless Software Networks Internet

MEDIA:

Logo
Logo

The Toro Company to Announce Fiscal 2020 Full-Year Results

The Toro Company to Announce Fiscal 2020 Full-Year Results

BLOOMINGTON, Minn.–(BUSINESS WIRE)–
The Toro Company (NYSE: TTC) today announced that it will release its fiscal 2020 full-year results on Wednesday, December 16, at approximately 7:30 a.m. CST. The full text of Toro’s earnings release will be available at that time at www.thetorocompany.com/invest. The company also will hold an earnings conference call at 10 a.m. CST that day.

A live, listen-only webcast of the earnings conference call will be available at www.thetorocompany.com/invest. Visitors are encouraged to go to the website in advance of the call to register, and download and install any necessary audio software.

For those unable to listen to the live webcast, a replay will be available at www.thetorocompany.com/invest.

About The Toro Company

The Toro Company (NYSE: TTC) is a leading worldwide provider of innovative solutions for the outdoor environment including turf and landscape maintenance, snow and ice management, underground utility construction, rental and specialty construction, and irrigation and outdoor lighting solutions. With sales of $3.1 billion in fiscal 2019, The Toro Company’s global presence extends to more than 125 countries through a family of brands that includes Toro, Ditch Witch, Exmark, BOSS Snowplow, Ventrac, American Augers, Subsite Electronics, HammerHead, Trencor, Unique Lighting Systems, Irritrol, Hayter, Pope, Lawn-Boy and Radius HDD. Through constant innovation and caring relationships built on trust and integrity, The Toro Company and its family of brands have built a legacy of excellence by helping customers care for golf courses, sports fields, construction sites, public green spaces, commercial and residential properties and agricultural operations. For more information, visit www.thetorocompany.com.

Investor Relations

Nicholas Rhoads

Managing Director, Investor Relations

(952) 887-8865, [email protected]

Media Relations

Branden Happel

Senior Manager, Public Relations

(952) 887-8930, [email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property Building Systems Automotive Manufacturing Landscape Other Construction & Property Manufacturing Residential Building & Real Estate

MEDIA:

Logo
Logo

Universal Insurance Holdings Declares Regular and Special Cash Dividends Totaling 29 Cents Per Share

Universal Insurance Holdings Declares Regular and Special Cash Dividends Totaling 29 Cents Per Share

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–
Universal Insurance Holdings, Inc. (NYSE: UVE) announced today that its Board of Directors has declared a quarterly regular and special cash dividend, together totaling 29 cents per share of common stock, payable December 18, 2020 to shareholders of record as of the close of business on December 11, 2020. The 29 cents per share dividend consists of a regular quarterly cash dividend of 16 cents per share and a special cash dividend of 13 cents per share, bringing the total regular and special dividends declared in 2020 to 77 cents per share.

About Universal Insurance Holdings, Inc.

Universal Insurance Holdings (UVE) is a holding company offering property and casualty insurance and value-added insurance services. We develop, market, and write insurance products for consumers predominantly in the personal residential homeowners lines of business and perform substantially all other insurance-related services for our primary insurance entities, including risk management, claims management and distribution. We sell insurance products through both our appointed independent agents and through our direct online distribution channels in the United States across 19 states (primarily Florida). Learn more at UniversalInsuranceHoldings.com.

Investor Relations Contact:

Rob Luther, 954-958-1200 ext. 6750

VP, Corporate Development, Strategy & IR

[email protected]

Media Relations Contact:

Andy Brimmer / Mahmoud Siddig, 212-355-4449

Joele Frank, Wilkinson Brimmer Katcher

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Insurance Professional Services

MEDIA:

Logo
Logo

Qurate Retail Announces Semi-Annual Interest Payment and Regular Additional Distribution on 4.0% Senior Exchangeable Debentures Due 2029

Qurate Retail Announces Semi-Annual Interest Payment and Regular Additional Distribution on 4.0% Senior Exchangeable Debentures Due 2029

ENGLEWOOD, Colo.–(BUSINESS WIRE)–
Qurate Retail, Inc. (“Qurate Retail”) (Nasdaq: QRTEA, QRTEB, QRTEP) today announced the payment of a semi-annual interest payment and a regular additional distribution to the holders as of November 1, 2020 of the 4.0% Senior Exchangeable Debentures due 2029 (the “Debentures”) issued by its wholly-owned subsidiary, Liberty Interactive LLC (“LI LLC”). The amount of the interest payment is $20.00 per $1,000 original principal amount of Debentures (a “Debenture”), and the amount of the additional distribution is $0.3930 per Debenture.

Under the Indenture for the Debentures, the original principal amount of the Debentures is reduced by an amount equal to each Extraordinary Additional Distribution made to holders of the Debentures. Thereafter, the adjusted principal amount is further reduced on each successive semi-annual interest payment date to the extent necessary to cause the semi-annual interest payment to represent the payment of an annualized yield of 4.0% of the adjusted principal amount. This latter adjustment, to the extent it is made by reason of a particular Extraordinary Additional Distribution that results in an adjustment to the principal amount of the Debentures, takes effect on the second succeeding interest payment date after the payment of that Extraordinary Additional Distribution.

To date, there has been one Extraordinary Additional Distribution to holders of the Debentures. On August 7, 2013, LI LLC made an Extraordinary Additional Distribution of $63.0960 per $1,000 original principal amount of the Debentures arising from the merger transaction between Sprint Nextel Corporation and SoftBank Corp.

Adjustments to the principal amount of the Debentures do not affect the amount of the semi-annual interest payments received by holders of the Debentures, which will continue to be a rate equal to 4.0% per annum of the original principal amount of the Debentures. Below is a detail of the amount of the semi-annual interest payment being made on the Debentures announced today, its allocation between payment of interest and repayment of principal and the revised adjusted principal amount resulting from such payment, per $1,000 original principal amount of the Debentures:

November 15, 2020 Beginning

Adjusted Principal

 

Total

Payment

 

Interest

 

Additional Payment

of Principal

 

November 15, 2020 Ending

Adjusted Principal

$918.3786

$20.0000

$18.3676

$1.6324

$916.7462

LI LLC is also making a regular additional distribution of $0.3930 per Debenture, attributable to the quarterly cash dividends paid by Century Link, Inc. (doing business as Lumen Technologies) of $0.25 per share on both June 12, 2020 and September 11, 2020. The regular additional distribution will not result in an adjustment to the adjusted principal amount of the Debentures.

The semi-annual interest payment and regular additional distribution are expected to be paid on November 16, 2020 to holders of record of the Debentures on November 1, 2020.

On April 1, 2020, T-Mobile US, Inc. completed its acquisition of Sprint Corporation (“TMUS/S Acquisition”) for 0.10256 shares of T-Mobile US, Inc. for every share of Sprint Corporation. Following the TMUS/S Acquisition, the reference shares attributable to each $1,000 original principal amount of Debentures consist of 0.3309 shares of common stock of T-Mobile US, Inc. (Nasdaq: TMUS) and 0.7860 shares of common stock of Century Link, Inc. (doing business as Lumen Technologies) (NYSE: LUMN).

About Qurate Retail, Inc.

Qurate Retail, Inc. operates and owns interests in a broad range of digital commerce businesses. Qurate Retail, Inc.’s businesses and assets consist of QVC (and its subsidiaries, including HSN), Zulily and the Cornerstone Brands (collectively, the Qurate Retail Group) as well as various green energy and other investments.

Courtnee Chun

720-875-5420

KEYWORDS: United States North America Colorado

INDUSTRY KEYWORDS: Retail Online Retail Luxury Fashion

MEDIA:

Logo
Logo

Fisker and Magna Achieve Key Engineering and Purchasing Milestones

Fisker and Magna Achieve Key Engineering and Purchasing Milestones

  • Fisker and Magna achieve Preliminary Product Specification, a key engineering and purchasing gateway, on the Fisker Ocean product program

LOS ANGELES–(BUSINESS WIRE)–
Fisker Inc. (NYSE: FSR) (“Fisker”) – designer and manufacturer of the world’s most emotion-stirring, eco-friendly electric vehicles and advanced mobility solutions – today confirmed that the company and Magna International Inc. (collectively with its affiliates, “Magna”) had completed the Preliminary Product Specification (PPS) gateway, a key engineering and purchasing milestone for the Fisker Ocean SUV. This milestone confirms preliminary specifications and targeted performance on key components and subsystems, as well as timing for all subsequent gateways through to the planned start of production in Q4, 2022.

“Today’s announcements demonstrate our team’s ability to set aggressive targets and achieve them on time,” commented Fisker Chairman and Chief Executive Officer, Henrik Fisker. “Completing these important engineering and purchasing milestones demonstrates how well the Fisker and Magna teams are working together and keeping our rapid, capital-light product development program on-track towards the delivery of the all-electric Fisker Ocean SUV, expected to commence in Q4 2022.”

On Oct. 15, 2020, Fisker and Magna announced they had entered into agreements to provide the framework for strategic platform sharing and manufacturing cooperation for the Fisker Ocean SUV. The Fisker Ocean will initially be manufactured exclusively by Magna in Europe, where it currently produces several high-quality vehicles on behalf of global brands. Fisker and Magna have agreed to work together to continue to develop new technologies that will accelerate innovation across multiple automotive systems and architectures for Fisker vehicles.

For more information, or for interview inquiries, contact [email protected].

About Fisker Inc.

California-based Fisker Inc. is revolutionizing the automotive industry by developing the most emotionally desirable and eco-friendly electric vehicles on Earth. Passionately driven by a vision of a clean future for all, the company is on a mission to become the No. 1 e-mobility service provider with the world’s most sustainable vehicles. To learn more, visit www.FiskerInc.com – and enjoy exclusive content across Fisker’s social media channels: Facebook, Instagram, Twitter, YouTube and LinkedIn. Download the revolutionary new Fisker mobile app from the App Store or Google Play store.

Forward Looking Statements

This press release includes forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “feel,” “believes,” expects,” “estimates,” “projects,” “intends,” “should,” “is to be,” or the negative of such terms, or other comparable terminology. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained herein due to many factors, including, but not limited to: Fisker’s limited operating history; Fisker’s ability to enter into platform and manufacturing contracts with Magna, or other OEMs or tier-one suppliers in order to execute on its business plan; Fisker’s ability to execute its business model, including market acceptance of its planned products and services; Fisker’s inability to retain key personnel and to hire additional personnel; competition in the electric vehicle market; Fisker’s inability to develop a sales distribution network; and the ability to protect its intellectual property rights. Any forward-looking statements speak only as of the date on which they are made, and Fisker undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

Fisker Inc.

Simon Sproule, SVP, Communications

310.374.6177 / [email protected]

Dan Galves, VP, Investor Relations

[email protected]

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Environment Alternative Energy Energy Automotive Engineering Automotive Manufacturing General Automotive Manufacturing

MEDIA:

Logo
Logo

SG Blocks Joint Venture Partnership Clarity Mobile Venture Selected as Trusted Testing Partner for Hawaii’s COVID-19 Travel Testing Program

SG Blocks Joint Venture Partnership Clarity Mobile Venture Selected as Trusted Testing Partner for Hawaii’s COVID-19 Travel Testing Program

NEW YORK–(BUSINESS WIRE)–SG Blocks, Inc. (Nasdaq: SGBX) (“SG Blocks” or the “Company”), a leading designer, innovator and fabricator of container-based structures, announced today that its Clarity Mobile Venture (“CMV”) partnership with Clarity Lab Solutions has been selected as a Trusted Testing Partner (TTP) for Hawaii’s COVID-19 travel testing program.

“Our scalable solution for COVID-19 testing has various use-cases, and CMV’s pre-travel service has been in serious demand,” stated Daniel Leger, President and Co-Founder of Clarity Lab Solutions. “With the knowledge of SG Blocks and their deployable modular laboratories and Clarity Lab Solutions’ experience in molecular diagnostics, we were able to fulfill the requirements put forth by Hawaii’s Department of Health to become a Trusted Testing Partner.”

“This is a huge step for our CMV partnership into the rapidly-growing and highly-profitable mobile laboratory market,” stated Paul Galvin, Chief Executive Officer of SG Blocks. “Our ability to combine Clarity’s PCR testing expertise and lab certification, with SG Blocks’ modular, efficient and quickly-deployable testing facilities positions us to assist Hawaii’s efforts to resume normal business and leisure travel activity as quickly and safely as possible.”

CMV has the ability to provide testing services that fulfill TTP requirements around the country and is currently in discussions for launching testing sites in localities that are ideal for testing passengers travelling to Hawaii. Initially, testing will be available in Southern California.

Hawaii’s COVID-19 travel testing program requires that all travelers, five years and older, arriving in the State of Hawaii may bypass the state’s mandatory 14-day quarantine by taking a COVID-19 Nucleic Acid Amplification Test (NAAT) from a trusted testing partner, including CMV. Partners were selected based on their ability to administer the test and expand the testing network, with the goal of making it easier to safely travel to Hawaii. The state will accept COVID-19 test results from the new partners starting November 17, 2020.

About SG Blocks:

SG Blocks, Inc. is a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction. The firm offers a product that exceeds many standard building code requirements, and also supports developers, architects, builders and owners in achieving greener construction, faster execution, and stronger buildings of higher value. Each project starts with GreenSteelTM, the structural core and shell of an SG Blocks building, and then customized to client specifications. For more information, visit www.sgblocks.com.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions and includes statements such as making it easier to safely travel to Hawaii. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to construct, deliver and deploy testing facilities to assist Hawaii’s efforts to resume normal business and leisure travel as planned, the Company’s ability to position itself for future profitability, , the Company’s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and the Company’s subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Media:

Rubenstein Public Relations

Christina Levin

Account Director

212-805-3029

[email protected]

Investors:

Stephen Swett

(203) 682-8377

[email protected]

KEYWORDS: New York Hawaii United States North America

INDUSTRY KEYWORDS: General Health Architecture Other Travel Other Construction & Property Infectious Diseases Commercial Building & Real Estate Travel Construction & Property Environment Maritime Transport Health Logistics/Supply Chain Management

MEDIA:

First Financial Northwest, Inc. Declares Quarterly Cash Dividend of $0.10 per Share

RENTON, Wash., Nov. 16, 2020 (GLOBE NEWSWIRE) — First Financial Northwest, Inc. (the “Company”) (NASDAQ GS: FFNW), the holding company for First Financial Northwest Bank (the “Bank”) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share on the Company’s outstanding common stock. The cash dividend will be payable on December 18, 2020, to shareholders of record on December 4, 2020.

First Financial Northwest, Inc. is the parent company of First Financial Northwest Bank; an FDIC insured Washington State-chartered commercial bank headquartered in Renton, Washington, serving the Puget Sound Region through 14 full-service banking offices. For additional information about us, please visit our website at ffnwb.com and click on the “Investor Relations” link at the bottom of the page.

Forward-looking statements:

When used in this press release and in other documents filed with or furnished to the Securities and Exchange Commission (the “SEC”), in press releases or other public stockholder communications, or in oral statements made with the approval of an authorized executive officer, the words or phrases “believe,” “will,” “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimate,” “project,” “plans,” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts but instead represent management’s current expectations and forecasts regarding future events many of which are inherently uncertain and outside of our control. Actual results may differ, possibly materially from those currently expected or projected in these forward-looking statements. Factors that could cause our actual results to differ materially from those described in the forward-looking statements, include, but are not limited to, the following: the effect of the COVID-19 pandemic, including on our credit quality and business operations, as well as its impact on general economic and financial market conditions and other uncertainties resulting from the COVID

19 pandemic, such as the extent and duration of the impact on public health, the U.S. and global economies, and consumer and corporate customers, including economic activity, employment levels and market liquidity; increased competitive pressures; changes in the interest rate environment; legislative and regulatory changes; and other factors described in the Company’s latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission – that are available on our website at www.ffnwb.com and on the SEC’s website at

www.sec.gov

.

Any of the forward-looking statements that we make in this Press Release and in the other public statements are based upon management’s beliefs and assumptions at the time they are made and may turn out to be wrong because of the inaccurate assumptions we might make, because of the factors illustrated above or because of other factors that we cannot foresee. Therefore, these factors should be considered in evaluating the forward-looking statements, and undue reliance should not be placed on such statements. We do not undertake and specifically disclaim any obligation to revise any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements. These risks could cause our actual results for 2020 and beyond to differ materially from those expressed in any forward-looking statements made by, or on behalf of, us and could negatively affect our operating and stock performance.

For more information, contact:
Joseph W. Kiley III, President and Chief Executive Officer
Rich Jacobson, Executive Vice President and Chief Financial Officer
(425) 255-4400



Navios Maritime Containers L.P. Receives Merger Proposal from Navios Maritime Partners L.P.

MONACO, Nov. 16, 2020 (GLOBE NEWSWIRE) — Navios Maritime Containers L.P. (“Navios Containers”) (NASDAQ: NMCI), an owner and operator of container vessels, announced today that its board of directors has received a proposal from Navios Maritime Partners L.P. (“Navios Partners”) (NYSE:NMM) pursuant to which Navios Partners would acquire the outstanding common units of Navios Containers not already owned by Navios Partners.

Subject to negotiation and execution of a definitive agreement, Navios Partners is proposing to issue in a merger transaction 0.37 of a common unit of Navios Partners for each outstanding common unit of Navios Containers. This exchange rate represents a value of $2.48 per common unit of Navios Containers.

The proposed transaction is subject to the negotiation and execution of a definitive agreement, approval of the board of directors of Navios Partners and the necessary approvals in accordance with Navios Containers’ limited partnership agreement. The consummation of the proposed transaction would be subject to customary closing conditions. There can be no assurance that any such approvals will be forthcoming, that a definitive agreement will be executed, or that any transaction will be consummated.

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities. This communication is not a substitute for any documents that may be filed with the Securities and Exchange Commission or sent to equity holders in connection with the proposed transaction. Equity holders are urged to read those documents, which will contain important information.

About Navios Maritime Containers L.P.

Navios Maritime Containers L.P. is a growth-oriented international owner and operator of containerships. For more information, please visit our website at www.navios-containers.com.

Advisory on Forward-Looking Information and Statements

This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and expectations. The words “believe,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “plan,” “potential,” “may,” “should,” “expect” “pending” and similar expressions identify forward-looking statements. Such statements are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. In addition, there is uncertainty about the spread of the COVID-19 virus and the impact it may have on the Company’s operations, the demand for the Company’s services, products, global supply chains and economic activity in general. Many factors could cause actual results to differ materially from the statements made, including those risks described from time to time in filings made by the Company with the Securities and Exchange Commission. The Company encourages you to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the Securities and Exchange Commission. Statements contained in this current press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not assume any obligation to update these forward-looking statements, other than as required by law.

Contact:

Navios Maritime Containers L.P.
+1.212.906.8648
[email protected]